Stay updated on Dolutegravir Plus NRTIs in HIV-2 Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.1 to v3.4.2; no changes to study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:55:47.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site shows a minor revision update from v3.4.0 to v3.4.1 with no visible changes to study data or page navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:21:07.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.1%
    Check dated 2026-01-15T04:51:30.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Footer metadata updated to Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed, and this change does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-24T14:48:10.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    Publications section text now states that publications are automatically populated from PubMed and may not pertain to the study. A Revision: v3.3.2 tag was added, replacing the previous v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T14:29:03.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    The government funding lapse notice about data currency and site operations has been removed, and the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:27:14.000Z thumbnail image

Stay in the know with updates to Dolutegravir Plus NRTIs in HIV-2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.